TY  - GEN
AU  - Jain,P
AU  - Aoki,E
AU  - Keating,M
AU  - Wierda,W G
AU  - O'Brien,S
AU  - Gonzalez,G N
AU  - Ferrajoli,A
AU  - Jain,N
AU  - Thompson,P A
AU  - Jabbour,E
AU  - Kanagal-Shamanna,R
AU  - Pierce,S
AU  - Alousi,A
AU  - Hosing,C
AU  - Khouri,I
AU  - Estrov,Z
AU  - Cortes,J
AU  - Kantarjian,H
AU  - Ravandi,F
AU  - Kadia,T M
TI  - Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)
SN  - 1569-8041
PY  - 2018///0129
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Chromosome Aberrations
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Karyotype
KW  - Leukemia, Prolymphocytic, T-Cell
KW  - Medical Records
KW  - Multivariate Analysis
KW  - Proportional Hazards Models
KW  - Recurrence
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Stem Cell Transplantation
KW  - Texas
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdx163
ER  -